Koios DS™ Thyroid
Smart Ultrasound software providing early and accurate thyroid cancer diagnosis.
FDA-Cleared • CE Marked • Billable Procedure
With a collection of algorithms utilizing over 2 million proprietary ultrasound images and analysis of over 17k features per image, the Koios DS Smart Ultrasound software uses AI to reliably classify and render breast cancer risk assessment.
Simplicity is key.
Koios decision support software integrates into most PACS workstations effectively taking malignancy risk assessment to the next level.
Select a region of interest for analysis.
In seconds, Koios DS analyzes and captures all nodule descriptors automatically and aligns to TI-RADS or ATA to dynamically calculate ratings.
Export the findings to a reporting system and save them as a secondary capture to PACS.
Research Proven
Participants interpreted studies with higher accuracy, faster interpretation and with less variability when utilizing Koios DS Thyroid vs a reader alone.
Across the full population of 15 readers and 650 cases (US + EU), results indicate a significant average relative improvement across multiple study end points with increased cancer detection and fewer benign biopsies.
Interpretation time: -24%
Sensitivity: + 14%
Specificity: + 37%
Variability: - 41%
SiiM: Society for Imaging Informatics in Medicine
More from Koios
Learn about our software solution for thyroid cancer detection.
